Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (70)

2024

  1. Trastuzumab deruxtecan in breast cancer

    Critical Reviews in Oncology/Hematology, Vol. 198

2023

  1. Do we really know if they are in pain? A cross-sectional study in hospitalised adult patients in Spain

    Nursing Open, Vol. 10, Núm. 12, pp. 7668-7675

  2. Reducing preoperative anxiety in parents of surgical patients

    Heliyon, Vol. 9, Núm. 5

  3. Utilización de medicamentos off-label y unlicensed en una unidad de cuidados intensivos pediátricos de un hospital de alta complejidad español. Estudio descriptivo

    Archivos argentinos de pediatria, Vol. 121, Núm. 1, pp. e202102550

2022

  1. Effect of Obesity and Roux-En-Y Gastric Surgery on Omeprazole Pharmacokinetics

    Obesity Facts, Vol. 15, Núm. 2, pp. 271-280

  2. Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study

    eClinicalMedicine, Vol. 51

  3. Utilización de medicamentos off-label y unlicensed en una unidad de cuidados intensivos pediátricos de un hospital de alta complejidad español. Estudio descriptivo

    Archivos Argentinos de Pediatria, Vol. 121, Núm. 1

2021

  1. Meta-Analysis of Reversal Agents for Severe Bleeding Associated With Direct Oral Anticoagulants

    Journal of the American College of Cardiology, Vol. 77, Núm. 24, pp. 2987-3001

2020

  1. Chiral bioanalytical methods in bioequivalence studies of intravenous vs. oral formulations of ibuprofen

    Chirality, Vol. 32, Núm. 9, pp. 1169-1177

  2. Phlebotonics for venous insufficiency

    Cochrane Database of Systematic Reviews, Vol. 2020, Núm. 11

2018

  1. Causes of Death in Patients with Venous Thromboembolism Anticoagulated with Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis

    Seminars in Thrombosis and Hemostasis, Vol. 44, Núm. 4, pp. 377-387

2016

  1. Adverse drug reactions in neonates: A prospective study

    Archives of Disease in Childhood, Vol. 101, Núm. 4, pp. 371-376

  2. Causes of Death in Anticoagulated Patients With Atrial Fibrillation

    Journal of the American College of Cardiology, Vol. 68, Núm. 23, pp. 2508-2521

  3. Direct oral anticoagulants for stroke prevention in patients with atrial fibrillation: meta-analysis by geographic region with a focus on European patients

    British Journal of Clinical Pharmacology, pp. 633-644

2015

  1. Case Fatality Rates of Recurrent Thromboembolism and Bleeding in Patients Receiving Direct Oral Anticoagulants for the Initial and Extended Treatment of Venous Thromboembolism

    Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 20, Núm. 5, pp. 490-500

  2. Direct-acting oral anticoagulants: Pharmacology, indications, management, and future perspectives

    European Journal of Haematology, Vol. 95, Núm. 5, pp. 389-404

2014

  1. Direct oral anticoagulants in the treatment of acute venous thromboembolism: A systematic review and meta-analysis

    Thrombosis Research, Vol. 134, Núm. 4, pp. 774-782

  2. Pharmacoeconomic Evaluation of Dabigatran, Rivaroxaban and Apixaban versus Enoxaparin for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement in Spain

    PharmacoEconomics, Vol. 32, Núm. 9, pp. 919-936

  3. Specific antidotes in development for reversal of novel anticoagulants: A review

    Recent Patents on Cardiovascular Drug Discovery, Vol. 9, Núm. 1, pp. 2-10

2012

  1. Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: Systematic review, meta-analysis, and indirect treatment comparisons

    BMJ (Online), Vol. 344, Núm. 7863